Tenet Healthcare Corporation (NYSE:THC – Get Free Report) Director Roy Blunt sold 600 shares of Tenet Healthcare stock in a transaction on Wednesday, August 5th. The shares were sold at an average price of $262.68, for a total value of $157,608.00. Following the completion of the transaction, the director owned 4,589 shares of the company’s stock, valued at approximately $1,205,438.52. This trade represents a 11.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Tenet Healthcare Stock Up 2.4%
Shares of THC stock traded up $6.11 during trading hours on Friday, reaching $262.75. 626,193 shares of the stock were exchanged, compared to its average volume of 1,488,050. Tenet Healthcare Corporation has a 12-month low of $157.58 and a 12-month high of $265.32. The business’s fifty day moving average is $200.19 and its two-hundred day moving average is $201.39. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The firm has a market capitalization of $21.16 billion, a P/E ratio of 10.13, a P/E/G ratio of 0.98 and a beta of 1.23.
Tenet Healthcare (NYSE:THC – Get Free Report) last posted its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The company had revenue of $6.04 billion during the quarter, compared to analysts’ expectations of $5.43 billion. During the same quarter in the previous year, the business posted $4.02 EPS. The firm’s revenue was up 6.8% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, research analysts expect that Tenet Healthcare Corporation will post 21.09 EPS for the current fiscal year.
Hedge Funds Weigh In On Tenet Healthcare
Analysts Set New Price Targets
A number of brokerages have issued reports on THC. Truist Financial lifted their price target on Tenet Healthcare from $270.00 to $290.00 and gave the stock a “buy” rating in a report on Tuesday, July 28th. Stephens reissued an “overweight” rating and set a $285.00 target price on shares of Tenet Healthcare in a research report on Monday, July 27th. Robert W. Baird upped their price target on Tenet Healthcare from $210.00 to $280.00 and gave the company a “neutral” rating in a report on Tuesday, July 28th. The Goldman Sachs Group reiterated a “buy” rating and issued a $305.00 price target on shares of Tenet Healthcare in a research note on Tuesday, July 28th. Finally, Royal Bank Of Canada boosted their price objective on shares of Tenet Healthcare from $236.00 to $283.00 and gave the stock an “outperform” rating in a research report on Monday, July 27th. Seventeen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, Tenet Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $271.00.
View Our Latest Analysis on THC
Tenet Healthcare Company Profile
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Further Reading
- Five stocks we like better than Tenet Healthcare
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
